Skip to main content

Teladoc Health, Inc.

TDOC
Exchange
NYSE
Industry
Services-Offices & Clinics of Doctors of Medicine
SEC CIK
0001477449

In the last 90 days, Teladoc Health, Inc. insiders filed 0 open-market purchases and 11 sales; 347 institutions reported holding it in 13F filings for Q2 2026, worth $1.29B in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $530.6K in total
11
13F holdersQ2 2026, +26 vs. previous quarter
347
13F valueReported value at the end of Q2 2026
$1.29B
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding TDOC, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding TDOC at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Teladoc Health, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2026 (view filing)4:05 PM ETSep 113 daysDivita Charles IIICHIEF EXECUTIVE OFFICERSSale−17.8K$6.10−$108.7K−3.7%465.5K after
Sep 3, 2026 (view filing)4:06 PM ETSep 21 dayNueno CarlosPresident, InternationalSSale−6.20K$6.30−$39.1K−8.7%64.7K after
Sep 3, 2026 (view filing)4:05 PM ETSep 21 dayVandervoort Adam CCHIEF LEGAL OFFICER, SECRETARYSSale−7.57K$6.30−$47.7K−6.0%117.6K after
Sep 3, 2026 (view filing)4:05 PM ETSep 21 dayBliss KellyPresident, U.S. Group HealthSSale−7.36K$6.30−$46.4K−7.3%92.8K after
Sep 3, 2026 (view filing)4:05 PM ETSep 21 dayCatapano Joseph RonaldChief Accounting OfficerSSale−274$6.30−$1.73K−2.1%12.9K after
Sep 3, 2026 (view filing)4:05 PM ETSep 21 dayDivita Charles IIICHIEF EXECUTIVE OFFICERSSale−18.3K$6.30−$115.5K−4.0%440.5K after
Sep 3, 2026 (view filing)4:05 PM ETSep 2-31 dayRodrigues Fernando M.President of BetterHelpSSale−15.3K$6.44−$98.1K−100.0%0 after2 lots10b5-1
Jul 6, 2026 (view filing)4:05 PM ETJul 6Same dayBliss KellyPresident, U.S. Group HealthSSale−2.50K$9.50−$23.8K−2.9%84.9K after10b5-1
Jul 6, 2026 (view filing)4:05 PM ETJul 24 daysCatapano Joseph RonaldChief Accounting OfficerSSale−653$9.10−$5.94K−5.1%12.3K after
Jul 1, 2026 (view filing)5:16 PM ETJul 1Same dayBliss KellyPresident, U.S. Group HealthSSale−2.50K$9.00−$22.5K−2.8%87.4K after10b5-1

Top 10 13F holders, Q2 2026

The largest institutional positions in Teladoc Health, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 347 holders
Institutions holding TDOC in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.16,223,134$137.6M0.00%+1,609,578+11.0%Added
Vanguard Portfolio Management LLC12,685,592$107.6M0.00%+390,498+3.2%Added
Point72 Asset Management, L.P.8,239,927$69.9M0.11%+518,432+6.7%Added
Renaissance Technologies LLC8,072,842$68.5M0.09%−12,700−0.2%Reduced
Voss Capital, LLC8,046,679$68.2M3.41%+3,846,679+91.6%Added
Vanguard Capital Management LLC7,955,032$67.5M0.00%+97,863+1.2%Added
Dimensional Fund Advisors LP7,371,699$62.5M0.01%+1,073,294+17.0%Added
State Street Corp4,962,382$42.1M0.00%+602,631+13.8%Added
American Century Companies Inc4,894,504$41.5M0.02%+1,438,120+41.6%Added
Allianz Asset Management GmbH4,666,596$39.6M0.04%−124,767−2.6%Reduced